Download PDF Flyer
Impact Factor Current: 2.642
5 - Year: 2.951

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Latest Issue: Volume 20 , Issue 14 , 2019

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.642
5 - Year: 2.951

Ranking & Category

  • 88th of 261 in Pharmacology & Pharmacy

Topics Covered

1 Topics

View
Covered Diseases

0 Diseases

View

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in


Science Citation Index Expanded® (Sci Search), Journal Citation Reports/Science Edition, InCites, Index to Scientific Reviews®, Biochemistry & Biophysics Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, ProQuest, ChemWeb, Google Scholar, MediaFinder-Standard Periodical Directory, Genamics Journal Seek, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Special Offers

Abstracted/Indexed in
Announcements
Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Forthcoming Special Issue(s)

Nanotechnology in biomedical applications
Guest Editor(s): Teresa Puig, Joaquim Ciurana
Tentative Publication Date: April, 2019

Submit Abstract via Email

Download Description

Published Special Issue(s)
Authors' Comments

It was a nice experience to publish our article in current drug target. I felt that the journal is quick and has maintained very high standard by independently reviewing article from more than five reviewers. The communication between the author and the Journals editorial is also speedy. I hope the journal will continue to maintain and sustain its reputation. 

Pushpender K. Sharma
(Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Pb, India.)